Development of a Prognostic AI-Monitor for Metastatic Urothelial Cancer Patients Receiving Immunotherapy

Development of a Prognostic AI-Monitor for Metastatic Urothelial Cancer Patients Receiving Immunotherapy

Background: Immune checkpoint inhibitor efficacy in advanced cancer patients remains difficult to predict. Imaging is the only technique available that can non-invasively provide whole body information of a patient's response to treatment. We hypothesize that quantitative whole-body prognostic...

Full description

Bibliographic Details
Main Authors: Stefano Trebeschi, Zuhir Bodalal, Nick van Dijk, Thierry N. Boellaard, Paul Apfaltrer, Teresa M. Tareco Bucho, Thi Dan Linh Nguyen-Kim, Michiel S. van der Heijden, Hugo J. W. L. Aerts, Regina G. H. Beets-Tan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
artificial intelligence
immunotherapy
checkpoint inhibitors
urothelial cancer
treatment monitoring
imaging - computed tomography
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.637804/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.637804/full

Similar Items